UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Prosperity Financial Group Inc.

Prosperity Financial Group Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 14.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,733 shares of the healthcare conglomerate’s stock after selling 300 shares during the period. Prosperity Financial Group Inc.’s holdings in UnitedHealth Group were worth $1,013,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. China Universal Asset Management Co. Ltd. grew its stake in shares of UnitedHealth Group by 20.6% in the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares in the last quarter. Quent Capital LLC raised its stake in shares of UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after purchasing an additional 217 shares during the period. Silvercrest Asset Management Group LLC boosted its stake in shares of UnitedHealth Group by 40.9% in the first quarter. Silvercrest Asset Management Group LLC now owns 25,170 shares of the healthcare conglomerate’s stock valued at $12,452,000 after purchasing an additional 7,308 shares during the period. Waverly Advisors LLC increased its stake in UnitedHealth Group by 15.3% during the 1st quarter. Waverly Advisors LLC now owns 11,193 shares of the healthcare conglomerate’s stock worth $5,537,000 after buying an additional 1,483 shares during the period. Finally, Industrial Alliance Investment Management Inc. boosted its position in UnitedHealth Group by 3.1% in the 1st quarter. Industrial Alliance Investment Management Inc. now owns 1,720 shares of the healthcare conglomerate’s stock valued at $851,000 after buying an additional 51 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on UNH. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Truist Financial restated a “buy” rating and issued a $625.00 price target (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

View Our Latest Analysis on UNH

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $590.87 on Monday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average is $582.63 and its two-hundred day moving average is $553.30. The firm has a market capitalization of $543.77 billion, a P/E ratio of 38.49, a PEG ratio of 1.73 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.